Files

Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.pdf (247.18 KB)

Embargo

Item embargoed until 2026-08-18

Document type

Article

Version

Accepted version

Publication date

2026-02-18

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/227620

Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1016/S2215-0366(26)00025-8

Abstract

Schizophrenia spectrum disorders (SSD) are among the leading global causes of disability, owing to chronic trajectories and high rates of treatment resistance. Antipsychotic medications are generally effective, but in up to a third of individuals with an acute episode, their symptoms show insufficient treatment response, underscoring the need to identify predictors of poor outcomes.

Subject

Psiquiatria infantil, Antipsiquiatria, Psicosi en els infants

Subject (English)

Child psychiatry, Antipsychiatry, Psychoses in children

Citation

Collections

Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

FARES OTERO, Natalia Elena, LEUCHT, Stefan and SEEDAT, Soraya. Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia. Lancet Psychiatry. 2026. Vol.  S2215-8. ISSN 2215-0374. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/227620

Export metadata

JSON - METS

Share record